CD4 and neoplasm: The immunoregulatory tryptophan-metabolizing enzymes indoleamin-2,3-dioxygenase (IDO) 1 and 2, are known to induce CD4+CD25+Foxp3+ regulatory T cells (Treg), which is a key player of suppressing anti-tumor immune responses [96].